Psyence Biomedical Ltd. (PBM) Stock Overview
Explore Psyence Biomedical Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Psyence Biomedical Ltd. (PBM)
Key Financials
Key Financials
Market Cap
60.3K
P/E Ratio
1.77
EPS (TTM)
$-389.98
ROE
-0.48%
PBM Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Psyence Biomedical Ltd. (PBM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 34.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 1.77 and a market capitalization of 60.3K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.